Cucurbitacin D
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Cucurbitacin D
Description:
Cucurbitacin D is the active ingredient in Trichosanthes kirilowii and can disrupt the interaction between Hsp90 and two co-chaperones, Cdc37 and p23. Cucurbitacin D is an inflammasome activator. Cucurbitacin D induces cell cycle arrest and cell apoptosis, exhibiting anti-tumor and anti-inflammatory effects[1][2][3][4].UNSPSC:
12352211Hazard Statement:
H300Target:
Apoptosis; HSPType:
Natural ProductsRelated Pathways:
Apoptosis; Cell Cycle/DNA Damage; Metabolic Enzyme/ProteaseApplications:
Cancer-programmed cell deathField of Research:
Cancer; Inflammation/ImmunologyAssay Protocol:
https://www.medchemexpress.com/cucurbitacin-d.htmlConcentration:
10mMPurity:
99.93Solubility:
DMSO : 110 mg/mL (ultrasonic)Smiles:
C[C@@]([C@@](CC=C(C(C)1C)[C@@]2([H])C[C@H](O)C1=O)([H])[C@@]2(C)C3=O)(C[C@@H](O)[C@]4([H])[C@@](C)(O)C(/C=C/C(C)(O)C)=O)[C@@]4(C3)CMolecular Formula:
C30H44O7Molecular Weight:
516.67Precautions:
H300References & Citations:
[1]Hall JA, et al. Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery. J Nat Prod. 2015 Apr 24;78 (4) :873-9.|[2]Jin Mo Ku, et al. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells. Mol Cell Biochem. 2015 Nov;409 (1-2) :33-43. |[3]Yuan Song, et al. Cucurbitacin D is a new inflammasome activator in macrophages. Int Immunopharmacol. 2013 Dec;17 (4) :1044-50.|[4]Mohammed Sikander, et al. Cucurbitacin D exhibits potent anti-cancer activity in cervical cancer. Sci Rep. 2016 Nov 8:6:36594.Shipping Conditions:
Room TemperatureStorage Conditions:
4°C (Powder, protect from light)Scientific Category:
Natural ProductsClinical Information:
No Development ReportedIsoform:
HSP90CAS Number:
[3877-86-9]
